Oncological outcomes of microscopic residual tumor after curative intended surgery in adenocarcinoma of esophagogastric junctio

Recruiting

• Conditions: Adenocarcinoma of esophagogastric junctionAdenocarcinoma of stomachResection categoryMicroscopic residual tumorOncological outcomes; Adenocarcinoma of esophagogastric junction; Adenocarcinoma of stomach; Resection category; Microscopic residual tumor; Oncological outcomes

• Registration Number: TCTR20220721004
• Lead Sponsor: Faculty of Medicine Siriraj Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-07-21
• Study Completion: 2022-09-04
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 420

Inclusion Criteria

Patients diagnosed with adenocarcinoma of esophagogastric junction and stomach
Underwent curative intended surgery

Exclusion Criteria

R2 resection
Neoadjuvant chemotherapy

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
5 year over all survival date of surgery to dead year

Secondary Outcome Measures

Name	Time	Method
3 year disease free survival date of surgery to recurrence year